Clinical Trial Update: Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing ENV-294 is being studied in adults with moderate-to-severe atopic dermatitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ENV-294

Snippet

Sponsor: Enveda Therapeutics | Conditions: Atopic Dermatitis (AD) | Phase 2 | Status: RECRUITING